Medigus Signed a Binding Letter of Intent with Polyrizon for an Investment in and Joint Commercialization of Biological Gels for Protecting Patients against COVID-19 and Other Biological Threats

• NASDAQ: $MDGS
• Notified: $1.52
• 07:00 EDT